Patients with Alzheimer's disease (AD) and their families must confront two fundamental truths. First, AD is a uniformly progressive disease that ultimately results in debilitating cognitive impairment. Second, although there is now evidence that some medications may produce transient improvement or
Assessment of progression and prognosis in ‘possible’ and ‘probable’ Alzheimer's disease
✍ Scribed by G. R. J. Swanwick; R. F. Coen; D. Coakley; B. A. Lawlor
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 99 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
✦ Synopsis
Objective. The objective of this study was to assess the rate of progression and clinical predictors of decline in subjects with possible' and probable' Alzheimer's disease (AD).
Design/setting. The annual rate of change (ARC) for cognitive/functional scales was calculated for 95 subjects with AD attending a memory clinic. Two consecutive ARCs were calculated for a subgroup of 39 subjects.
Results. The ARCs were relatively normally distributed; however, there was a large degree of variability. Neither age nor duration of symptoms at presentations were predictive of the rate of decline. However, the data suggested an eect of gender, with males having a greater rate of decline in cognition ( p 0.02). Finally, the rate of progression over the ®rst year did not predict the subsequent ARC ( p 0.25).
Conclusions. The high variability in ARCs observed in this study and poor correlation between consecutive ARCs suggest that neither mean ARC values nor the previous rate of decline can be used to aid clinicians in the assessment of response to acetylcholinesterase inhibitors or other speci®c treatments for AD.
📜 SIMILAR VOLUMES
We assessed a consecutive series of 398 patients with probable Alzheimer's disease (AD) for the presence of Generalized Anxiety Disorder (GAD) using a standardized neuropsychiatric evaluation. Five percent of patients showed GAD during the 4 weeks preceding the psychiatric evaluation. AD patients wi
Objectives. This study examined the prevalence and clinical correlates of Capgras syndrome (CS) in Alzheimer's disease. Design. Cross-sectional study of elderly patients evaluated at an outpatient memory disorders clinic classi®ed according to the presence or absence of CS. Subjects. One hundred a
## Background: Local recurrence of melanoma is associated with a grave prognosis. however, the characteristics and the mode of disease progression for patients with local recurrence have not been adequately addressed in the literature. ## Methods: A retrospective analysis of patients treated at a